Publicaciones
- 
                        Iglesias M, Aznar I, Gil MM, Moreno-Peral P, Peñarrubia-María MT, Rubio-Valera M and Serrano-Blanco A. Comparing watchful waiting with antidepressants for the management of subclinical depression symptoms to mild-moderate depression in primary care: a systematic review.FAMILY PRACTICE . 34(6): 639-648. Nº de citas: 12 
- 
                        Andrés L, Pérez A, Feliu A, Rubio-Valera M, Aznar I, Serrano-Blanco A, Juncosa M, Tosas A, Bernadàs A and Luciano JV. Effectiveness of the What's Up! Intervention to Reduce Stigma and Psychometric Properties of the Youth Program Questionnaire (YPQ): Results from a Cluster Non-randomized Controlled Trial Conducted in Catalan High Schools.FRONTIERS IN PSYCHOLOGY . 8: 1608-1608. Nº de citas: 15 
- 
                        Serrano-Blanco A, Guitart-Pardellans C, Balaguer-Gargallo M, Flores-González C and Jordán-García I. Avaluació de les aportacions nutricionals en els lactants amb bronquiolitis aguda greu/ Nutritional support for infants with severe bronchiolitis.Pediatría Catalana . 77(3): 91-96. 
- 
                        Aznar I, Fernández A, Gil MM, Sabés-Figuera R, Fajó-Pascual M, Peñarrubia-María MT, Serrano-Blanco A, Moreno-Peral P, Sánchez-Niubó A, March-Pujol M and Rubio-Valera M. Impact of initial medication non-adherence on use of healthcare services and sick leave: a longitudinal study in a large primary care cohort in Spain.BRITISH JOURNAL OF GENERAL PRACTICE . 67(662): 614-622. Nº de citas: 22 
- 
                        Cuevas-Esteban J, Iglesias M, Rubio-Valera M, Serra-Mestres J, Serrano-Blanco A and Baladon L. Prevalence and characteristics of catatonia on admission to an acute geriatric psychiatry ward.PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY . 78: 27-33. Nº de citas: 27 
- 
                        Luciano JV, Francesco D'Amico, Feliu A, McCracken LM, Aguado J, Peñarrubia-María MT, Martin Knapp, Serrano-Blanco A and García-Campayo J. Cost-Utility of Group Acceptance and Commitment Therapy for Fibromyalgia Versus Recommended Drugs: An Economic Analysis Alongside a 6-Month Randomized Controlled Trial Conducted in Spain (EFFIGACT Study).JOURNAL OF PAIN . 18(7): 868-880. Nº de citas: 34 
- 
                        Serrano-Blanco A, Rubio-Valera M, Aznar I, Baladon L, Gibert K, Gracia Canales A, Kaskens L, Ortiz JM and Salvador-Carulla L. In-patient costs of agitation and containment in a mental health catchment area.BMC Psychiatry . 17(1): 212-212. Nº de citas: 27 
- 
                        Aznar I, Fernández A, Gil MM, Fajó-Pascual M, Moreno-Peral P, Peñarrubia-Teresa MT, Serrano-Blanco A, Sánchez-Niubó A, March-Pujol MA, Jové AM and Rubio-Valera M. Initial medication non-adherence: prevalence and predictive factors in a cohort of 1.6 million primary care patients.BRITISH JOURNAL OF CLINICAL PHARMACOLOGY . 83(6): 1328-1340. Nº de citas: 36 
- 
                        Mugica F, Nebot À, Bagherpour S, Baladon L and Serrano-Blanco A. A model for continuous monitoring of patients with major depression in short and long term periods.TECHNOLOGY AND HEALTH CARE . 25(3): 487-511. Nº de citas: 3 
- 
                        Luciano JV, Carlos Garcia Forero, Marta Cerdà Lafont, Peñarrubia-María MT, Fernández-Vergel R, JOSE MIGUEL RUIZ MARTIN, Rozadilla A, Sirvent Alierta, Elena, Santo Panero, Pilar, García Campayo, Javier, Serrano-Blanco A and Rubio-Valera M. Functional Status, Quality of Life, and Costs Associated With Fibromyalgia Subgroups: A Latent Profile Analysis.CLINICAL JOURNAL OF PAIN . 32(10): 829-840. Nº de citas: 36 
